Heart attacks are an inflammatory condition, and a new study suggests the mRNA injections produced by both Pfizer and Moderna are raising inflammatory blood markers used to estimate the risk of a person suffering a heart attack.
The new higher markers hint that in the study group of 500 patients, the 5 year risk of a heart attack has doubled, from 11% to 25%.
Dr Aseem Malhotra, a consultant cardiologist, points out that in the UK there have been 10,000 excess non-Covid deaths — many of which were due to heart attack and stroke. If the mRNA vaccines were increasing the risk of heart attacks, even temporarily, this would explain some of the excess deaths. Inflammation might be temporary, but death usually isn’t.
A few days after these ominous results came out, a whistleblower and researcher from a different group contacted Dr Aseem Malhotra to say that in imaging studies they have found inflammation in the coronary arteries after vaccination. But they decided not to publish this yet because they are afraid of losing future grant money from the drug industry. The whistleblower was quite upset about this. Understandably.
Malhotra also mentions that he’s heard from other medical workers that there has been an increase in heart attacks in the UK, and in younger people.
Dr Malhotra mentions results from the “Steven Gundry paper”. Gundry’s group has used a standard test to predict the risk of heart attacks in their patients for the last eight years. But they noticed that some of the blood markers they were looking for in the test were significantly higher after the second mRNA vaccination dose.
We conclude that the mRNA vacs dramatically increase inflammation on the endothelium and T cell infiltration of cardiac muscle and may account for the observations of increased thrombosis, cardiomyopathy, and other vascular events following vaccination.
The blood markers they use in the PLUS Cardiac Test (GD Biosciences) include inflammatory molecules like Interleukin-16 (IL-16), as well as other like soluble Fas, and Hepatocyte Growth Factor (HGF). People at risk of cardiac arrest would typically get measured every 3 – 6 months.